Many viral agents causing lesions of the skin and mucous membranes persist for a long time in the human body, causing secondary immunosuppression. Inosine pranobex with simultaneously immunomodulatory and antiviral activity, contributing to the active elimination of the virus from the body, is effective both in the treatment and prevention of various viral dermatoses. Numerous clinical studies, as well as the experience of the use of the drug in more than 70 countries around the world, indicate the efficacy and safety of inosine pranobex for the treatment of patients with confirmed viral infections.

Keywords: herpes, skin, Inosine pranobex, immunomodulators, antiviral drugs, human papillomavirus